Image Navigation to Launch Newest Image Guided Implantology Technology at the European Academy of Osseointegration Congress in Geneva

Dual surgical navigation and robotic system - without the robot - for dental implantology to be exhibited September 29-October 1

Image Navigation Ltd., a pioneer in surgical navigation systems, will launch their second generation Image Guided Implantology (IGI) system during the EAO Congress in Geneva next week, the company announced today.

The IGI system brings the precision of navigation and the safety of robotic tools to the field of dental implantology.  Its new transformative robotic Auto-stop feature stops the drill when it is outside the planned trajectory or location, thereby providing robotic surgery without the robot.  The foundation of Auto-stop is Image Navigation’s proprietary high accuracy, no-observable-lag tracking.

The Image Navigation proprietary patient-to-system connector enables a smooth and efficient chairside workflow without compromising its sub-mm pinpoint accuracy.  This allows the surgeon to focus on the patient – rather than constantly monitoring the connector for movement or rotation. The system enables both same day scan, plan and surgery, as well as surgery at a date subsequent to the CT scan, without any diminution of accuracy.

Lawrence Obstfeld, CEO of Image Navigation, said, “Our IGI 2.0 is a Waze for dental implantology, providing the highest accuracy in implant surgery together with the safety of robotics – without a large and expensive robot in the surgical field.  The surgeon navigates in real-time, according to the pre-surgical plan.  The auto-stop will disable the drill if it is not following the on-screen indicators displayed on the screen.  This new IGI 2.0 will usher in an exciting era of navigated and robotic dentistry.”

IGI extends the use of 3D dental CT scans from diagnosis and planning to the actual surgical procedure. The pre-op CT image is utilized as a detailed on-screen map, providing the surgeon with precise real-time visualization of the direction, position and depth of the drill tip. The current installed base of 120,000 Dental CT scanners worldwide represents about $5B in capital investment.

IGI version 2.0 is anticipated to reach the European market in H1 2023.

Image Navigation Ltd. will be exhibiting the new IGI 2.0 at the European Academy of Osseointegration Congress, at Palexpo Geneva, Switzerland, September 29 – October 1, Booth H31.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”